HUBER & SCHÜSSLER
   Patentanwälte Patent Attorneys

Biotechnology

 

 

 

Introduction

 

Urged on by the German Federal Government's "BioRegio" competition in the late 1990s, a large number of start-up companies in the Biotech and Life Science field have been founded in the past few years. For these companies, patents often represent the single most important asset of their existence. 

Not only are these small companies interested in patent protection but also large pharmaceutical companies pursue patent protection for their products on the market, as well as for potential products in the pipeline. In addition, the large pharmaceutical companies feel the pressure to switch to the new biotechnologies to avoid "missing the boat". 

Universities and research institutes have also begun to recognize that their basic research creates patentable subject matter which can be sold or licenced to commercial companies.

Thus, our Life Science clients are engaged in many fields, including:

Biotechnology

Bioinformatics

Diagnostics

Ag-Bio

Drug Delivery

Genomics

Medical Devices

Pharmaceuticals

Proteomics

For further information on the patenting of inventions in the biotech and life science field see:

General Introduction to Patents

Protection of biotechnological inventions in the European Union

 

   

 

 

Home ] Up ] Biotechnology ]

Copyright © 2001, 2002 Huber & Schüssler Patentanwälte